Medtronic Expands Transcatheter Mitral Effort With Acquisition Of Twelve Inc.
This article was originally published in Clinica
The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic's $458m acquisition of Twelve, Inc.
You may also be interested in...
The deal gives Medtronic the exclusive right to acquire Half Moon Medical, a start-up developing a mitral valve repair system to compete with Abbott’s MitraClip.
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.